Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1501 AL 1515

Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease

Itoh Y, Voskuhl RR.

PLoS One. 2017 Jul 17;12(7):e0181349. doi: 10.1371/journal.pone.0181349. eCollection 2017.

Parkinson's disease and Parkinson's disease psychosis: a perspective on the challenges, treatments, and economic burden

Fredericks D, Norton JC, Atchison C, Schoenhaus R, Pill MW.

Am J Manag Care. 2017 Apr;23(5 Suppl):S83-S92.

Parkin mutation may be associated with serious akinesia in a patient with Parkinson's disease

Uchihara Y, Kataoka H, Yoshino H, Syobatake R, Hattori N, Ueno S.

J Neurol Sci. 2017 Aug 15;379:119-121. doi: 10.1016/j.jns.2017.05.065. Epub 2017 May 31.

Psychosis in Parkinson's disease: From the soft signs to the hard science

Lenka A, Herath P, Christopher R, Pal PK.

J Neurol Sci. 2017 Aug 15;379:169-176. doi: 10.1016/j.jns.2017.06.011. Epub 2017 Jun 12.

Dalfampridine in Parkinson's disease related gait dysfunction: A randomized double blind trial

Luca CC, Nadayil G, Dong C, Nahab FB, Field-Fote E, Singer C.

J Neurol Sci. 2017 Aug 15;379:7-11. doi: 10.1016/j.jns.2017.05.011. Epub 2017 May 6.

Parkinson's Disease and Its Effect on the Lower Urinary Tract: Evaluation of Complications and Treatment Strategies

Brucker BM, Kalra S.

Urol Clin North Am. 2017 Aug;44(3):415-428. doi: 10.1016/j.ucl.2017.04.008.

Disease-Specific Outcomes of Botulinum Toxin Injections for Neurogenic Detrusor Overactivity

Kaviani A, Khavari R.

Urol Clin North Am. 2017 Aug;44(3):463-474. doi: 10.1016/j.ucl.2017.04.012.

Levodopa in Parkinson's Disease: A Review of Population Pharmacokinetics/Pharmacodynamics Analysis

Marsot A, Guilhaumou R, Azulay JP, Blin O.

J Pharm Pharm Sci. 2017;20(0):226-238. doi: 10.18433/J30H04.

Parasomnia overlap disorder, Parkinson's disease and subthalamic deep brain stimulation: three case reports

Bargiotas P, Muellner J, Schuepbach WMM, Bassetti CL.

BMC Neurol. 2017 Jul 18;17(1):137. doi: 10.1186/s12883-017-0916-0.

Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models

Lopes FM, Bristot IJ, da Motta LL, Parsons RB, Klamt F.

Neuromolecular Med. 2017 Sep;19(2-3):241-255. doi: 10.1007/s12017-017-8454-x. Epub 2017 Jul 18.

VCP-related multisystem proteinopathy presenting as early-onset Parkinson disease

Regensburger M, Türk M, Pagenstecher A, Schröder R, Winkler J.

Neurology. 2017 Aug 15;89(7):746-748. doi: 10.1212/WNL.0000000000004240. Epub 2017 Jul 19.

Cell replacement therapy is the remedial solution for treating Parkinson's disease

Dhivya V, Balachandar V.

Stem Cell Investig. 2017 Jun 30;4:59. doi: 10.21037/sci.2017.06.08. eCollection 2017.

The effect of deep brain stimulation on the non-motor symptoms of Parkinson's disease: a critical review of the current evidence

Kurtis MM, Rajah T, Delgado LF, Dafsari HS.

NPJ Parkinsons Dis. 2017 Jan 12;3:16024. doi: 10.1038/npjparkd.2016.24. eCollection 2017.

[Parkinson's disease in the elderly]

Lange R, Erbguth F.

Z Gerontol Geriatr. 2017 Aug;50(6):547-559. doi: 10.1007/s00391-017-1284-5. Epub 2017 Jul 19.

Quantification of Hand Motor Symptoms in Parkinson's Disease: A Proof-of-Principle Study Using Inertial and Force Sensors

van den Noort JC, Verhagen R, van Dijk KJ, Veltink PH, Vos MCPM, de Bie RMA, Bour LJ, Heida CT.

Ann Biomed Eng. 2017 Oct;45(10):2423-2436. doi: 10.1007/s10439-017-1881-x. Epub 2017 Jul 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias